Pituitary Cell Turnover: From Adult Stem Cell Recruitment through Differentiation to Death

Neuroendocrinology

Volumn 101, Issue 3, 2015, Pages 175-192

  Garcia Lavandeira, Montserrat ^a   Diaz Rodriguez, Esther ^a   Bahar, Dilek ^a   Garcia Rendueles, Angela R ^a   Rodrigues, Joana S ^a   Dieguez, Carlos ^a   Alvarez, Clara V ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Arf; GDNF; Hypopituitarism; p53; Pit 1; Pituitary; Pituitary tumors; Ret; Stem cells

Indexed keywords

ARF PROTEIN; CASPASE 3; NESTIN; PROTEIN P53; PROTEIN RET; TRANSCRIPTION FACTOR PIT 1;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL RENEWAL; CELL SURVIVAL; GROWTH HORMONE SECRETING CELL; HOMEOSTASIS; HUMAN; HYPERPLASIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; LACTATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PUBERTY; SECRETORY CELL; STEM CELL NICHE; ADULT STEM CELL; ANIMAL; ANIMAL MODEL; CYTOLOGY; HYPOPHYSIS; PHYSIOLOGY;

ADULT STEM CELLS; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; HUMANS; MODELS, ANIMAL; PITUITARY GLAND; STEM CELL NICHE;

EID: 84931956640     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000375502     Document Type: Article

References (116)

1. Melmed S: Mechanisms for pituitary tumorigenesis: The plastic pituitary. J Clin Invest 2003; 112: 1603-1618.
2. Perez-Castro C, Renner U, Haedo MR, Stalla GK, Arzt E: Cellular and molecular specificity of pituitary gland physiology. Physiol Rev 2012; 92: 1-38.
3. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE: The prevalence of pituitary adenomas: A systematic review. Cancer 2004; 101: 613-619.
4. Castinetti F, Davis SW, Brue T, Camper SA: Pituitary stem cell update and potential implications for treating hypopituitarism. Endocr Rev 2011; 32: 453-471.
5. Vankelecom H, Gremeaux L: Stem cells in the pituitary gland: A burgeoning field. Gen Comp Endocrinol 2010; 166: 478-488.
6. Vankelecom H, Chen J: Pituitary stem cells: where do we stand? Mol Cell Endocrinol 2014; 385: 2-17.
7. Tang F, Barbacioru C, Bao S, Lee C, Nordman E, Wang X, Lao K, Surani MA: Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis. Cell Stem Cell 2010; 6: 468-478.
8. Pera MF, Tam PP: Extrinsic regulation of pluripotent stem cells. Nature 2010; 465: 713-720.
9. Pera MF: Defining pluripotency. Nat Methods 2010; 7: 885-887.
10. Kalkan T, Smith A: Mapping the route from naive pluripotency to lineage specification. Philos Trans R Soc Lond B Biol Sci 2014; 369: 20130540.
11. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B: Sox9 is required for cartilage formation. Nat Genet 1999; 22: 85-89.
12. Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST: Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. Am J Physiol Gastrointest Liver Physiol 2009; 296:G1108-G1118.
13. Scott CE, Wynn SL, Sesay A, Cruz C, Cheung M, Gomez Gaviro MV, Booth S, Gao B, Cheah KS, Lovell-Badge R, Briscoe J: SOX9 induces and maintains neural stem cells. Nat Neurosci 2010; 13: 1181-1189.
14. Mardaryev AN, Meier N, Poterlowicz K, Sharov AA, Sharova TY, Ahmed MI, Rapisarda V, Lewis C, Fessing MY, Ruenger TM, Bhawan J, Werner S, Paus R, Botchkarev VA: Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development 2011; 138: 4843-4852.
15. Garcia-Lavandeira M, Saez C, Diaz-Rodriguez E, Perez-Romero S, Senra A, Dieguez C, Japon MA, Alvarez CV: Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. J Clin Endocrinol Metab 2012; 97:E80-E87.
16. Alvarez CV, Garcia-Lavandeira M, Garcia-Rendueles ME, Diaz-Rodriguez E, Garcia-Rendueles AR, Perez-Romero S, Vila TV, Rodrigues JS, Lear PV, Bravo SB: Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells. J Mol Endocrinol 2012; 49:R89-R111.
17. Kawaguchi Y: Sox9 and programming of liver and pancreatic progenitors. J Clin Invest 2013; 123: 1881-1886.
18. Garcia-Lavandeira M, Quereda V, Flores I, Saez C, Diaz-Rodriguez E, Japon MA, Ryan AK, Blasco MA, Dieguez C, Malumbres M, Alvarez CV: A GRFa2/Prop1/stem (GPS) cell niche in the pituitary. PLoS One 2009; 4:e4815.
19. Meng X, Lindahl M, Hyvonen ME, Parvinen M, de Rooij DG, Hess MW, Raatikainen-Ahokas A, Sainio K, Rauvala H, Lakso M, Pichel JG, Westphal H, Saarma M, Sariola H: Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 2000; 287: 1489-1493.
20. Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M, Orwig KE, Wolgemuth DJ, Pandolfi PP: Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet 2004; 36: 653-659.
21. Linher K, Wu D, Li J: Glial cell line-derived neurotrophic factor: an intraovarian factor that enhances oocyte developmental competence in vitro. Endocrinology 2007; 148: 4292-4301.
22. Kawamura K, Ye Y, Kawamura N, Jing L, Groenen P, Gelpke MS, Rauch R, Hsueh AJ, Tanaka T: Completion of Meiosis I of preovulatory oocytes and facilitation of preimplantation embryo development by glial cell line-derived neurotrophic factor. Dev Biol 2008; 315: 189-202.
23. Li J, Klein C, Liang C, Rauch R, Kawamura K, Hsueh AJ: Autocrine regulation of early embryonic development by the artemin-GFRA3 (GDNF family receptor-alpha 3) signaling system in mice. FEBS Lett 2009; 583: 2479-2485.
24. Fonseca-Pereira D, Arroz-Madeira S, Rodrigues-Campos M, Barbosa IA, Domingues RG, Bento T, Almeida AR, Ribeiro H, Potocnik AJ, Enomoto H, Veiga-Fernandes H: The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function. Nature 2014; 514: 98-101.
25. Chen J, Hersmus N, Van Duppen V, Caesens P, Denef C, Vankelecom H: The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 2005; 146: 3985-3998.
26. Lepore DA, Roeszler K, Wagner J, Ross SA, Bauer K, Thomas PQ: Identification and enrichment of colony-forming cells from the adult murine pituitary. Exp Cell Res 2005; 308: 166-176.
27. Chen J, Crabbe A, Van Duppen V, Vankelecom H: The notch signaling system is present in the postnatal pituitary: marked expression and regulatory activity in the newly discovered side population. Mol Endocrinol 2006; 20: 3293-3307.
28. Lepore DA, Jokubaitis VJ, Simmons PJ, Roeszler KN, Rossi R, Bauer K, Thomas PQ: A role for angiotensin-converting enzyme in the characterization, enrichment, and proliferation potential of adult murine pituitary colony-forming cells. Stem Cells 2006; 24: 2382-2390.
29. Lepore DA, Thomas GP, Knight KR, Hussey AJ, Callahan T, Wagner J, Morrison WA, Thomas PQ: Survival and differentiation of pituitary colony-forming cells in vivo. Stem Cells 2007; 25: 1730-1736.
30. Fauquier T, Rizzoti K, Dattani M, Lovell-Badge R, Robinson IC: SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci USA 2008; 105: 2907-2912.
31. Chen J, Gremeaux L, Fu Q, Liekens D, Van Laere S, Vankelecom H: Pituitary progenitor cells tracked down by side population dissection. Stem Cells 2009; 27: 1182-1195.
32. Correr S, Motta P: The rat pituitary cleft: A correlated study by scanning and transmission electron microscopy; in Allen DJ (ed): Three Dimensional Microanatomy of Cells and Tissue Surfaces: Proceedings of the Symposium on Three Dimensional Microanatomy Held in Mexico City, Aug. 17-23, 1980. New York, Elsevier/ North-Holland, 1981, pp 69-82.
33. Correr S, Motta PM: The rat pituitary cleft: A correlated study by scanning and transmission electron microscopy. Cell Tissue Res 1981; 215: 515-529.
34. Correr S, Motta PM: A scanning electron-microscopic study of 'supramarginal cells' in the pituitary cleft of the rat. Cell Tissue Res 1985; 241: 275-281.
35. Le Tissier PR, Hodson DJ, Lafont C, Fontanaud P, Schaeffer M, Mollard P: Anterior pituitary cell networks. Front Neuroendocrinol 2012; 33: 252-266.
36. Yoshida S, Kato T, Yako H, Susa T, Cai LY, Osuna M, Inoue K, Kato Y: Significant quantitative and qualitative transition in pituitary stem/ progenitor cells occurs during the postnatal development of the rat anterior pituitary. J Neuroendocrinol 2011; 23: 933-943.
37. Anversa P, Kajstura J, Leri A, Loscalzo J: Tissuespecific adult stem cells in the human lung. Nat Med 2011; 17: 1038-1039.
38. Kajstura J, Rota M, Hall SR, Hosoda T, D'Amario D, Sanada F, Zheng H, Ogorek B, Rondon-Clavo C, Ferreira-Martins J, Matsuda A, Arranto C, Goichberg P, Giordano G, Haley KJ, Bardelli S, Rayatzadeh H, Liu X, Quaini F, Liao R, Leri A, Perrella MA, Loscalzo J, Anversa P: Evidence for human lung stem cells. N Engl J Med 2011; 364: 1795-1806.
39. Gage PJ, Roller ML, Saunders TL, Scarlett LM, Camper SA: Anterior pituitary cells defective in the cell-autonomous factor, df, undergo cell lineage specification but not expansion. Development 1996; 122: 151-160.
40. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG: Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996; 384: 327-333.
41. Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JA 3rd, Rosenfeld MG: Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18: 147-149.
42. Nasonkin IO, Ward RD, Raetzman LT, Seasholtz AF, Saunders TL, Gillespie PJ, Camper SA: Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet 2004; 13: 2727-2735.
43. Ward RD, Raetzman LT, Suh H, Stone BM, Nasonkin IO, Camper SA: Role of PROP1 in pituitary gland growth. Mol Endocrinol 2005; 19: 698-710.
44. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT: Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 2009; 30: 790-829.
45. Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R, Rose D, Li X, Rosenfeld MG: Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell 2006; 125: 593-605.
46. Sugiyama Y, Ikeshita N, Shibahara H, Yamamoto D, Kawagishi M, Iguchi G, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y: A PROP1-binding factor, AES cloned by yeast two-hybrid assay represses PROP1-induced Pit-1 gene expression. Mol Cell Endocrinol 2013; 376: 93-98.
47. Chambers I, Tomlinson SR: The transcriptional foundation of pluripotency. Development 2009; 136: 2311-2322.
48. Kopp JL, Ormsbee BD, Desler M, Rizzino A: Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 2008; 26: 903-911.
49. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113: 631-642.
50. Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24: 372-376.
51. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007.
52. Imayoshi I, Isomura A, Harima Y, Kawaguchi K, Kori H, Miyachi H, Fujiwara T, Ishidate F, Kageyama R: Oscillatory control of factors determining multipotency and fate in mouse neural progenitors. Science 2013; 342: 1203-1208.
53. Lendahl U, Zimmerman LB, McKay RD: CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-595.
54. Krylyshkina O, Chen J, Mebis L, Denef C, Vankelecom H: Nestin-immunoreactive cells in rat pituitary are neither hormonal nor typical folliculo-stellate cells. Endocrinology 2005; 146: 2376-2387.
55. Gautron L, De-Smedt V, Laye S: Age-related changes in nestin immunoreactivity in the rat pituitary gland. Neuroendocrinology 2009; 90: 19-30.
56. Perez-Millan MI, Berner SI, Luque GM, De Bonis C, Sevlever G, Becu-Villalobos D, Cristina C: Enhanced nestin expression and small blood vessels in human pituitary adenomas. Pituitary 2013; 16: 303-310.
57. Horvath E, Coire CI, Kovacs K, Smyth HS: Folliculo-stellate cells of the human pituitary as adult stem cells: examples of their neoplastic potential. Ultrastruct Pathol 2010; 34: 133-139.
58. Gleiberman AS, Michurina T, Encinas JM, Roig JL, Krasnov P, Balordi F, Fishell G, Rosenfeld MG, Enikolopov G: Genetic approaches identify adult pituitary stem cells. Proc Natl Acad Sci USA 2008; 105: 6332-6337.
59. Galichet C, Lovell-Badge R, Rizzoti K: Nestin-Cre mice are affected by hypopituitarism, which is not due to significant activity of the transgene in the pituitary gland. PLoS One 2010; 5:e11443.
60. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS: Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
61. Ding L, Saunders TL, Enikolopov G, Morrison SJ: Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481: 457-462.
62. Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K, Mar JC, Bergman A, Frenette PS: Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 2013; 502: 637-643.
63. Mabuchi Y, Houlihan DD, Akazawa C, Okano H, Matsuzaki Y: Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers. Stem Cells Int 2013; 2013: 507301.
64. Gilyarov AV: Nestin in central nervous system cells. Neurosci Behav Physiol 2008; 38: 165-169.
65. Rotondo F, Kovacs K, Horvath E, Bell CD, Lloyd RV, Scheithauer BW: Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms. Acta Neuropathol 2006; 111: 272-277.
66. Shamblott MJ, Axelman J, Littlefield JW, Blumenthal PD, Huggins GR, Cui Y, Cheng L, Gearhart JD: Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci USA 2001; 98: 113-118.
67. Bignami A, Raju T, Dahl D: Localization of vimentin, the nonspecific intermediate filament protein, in embryonal glia and in early differentiating neurons. In vivo and in vitro immunofluorescence study of the rat embryo with vimentin and neurofilament antisera. Dev Biol 1982; 91: 286-295.
68. Gremeaux L, Fu Q, Chen J, Vankelecom H: Activated phenotype of the pituitary stem/progenitor cell compartment during the earlypostnatal maturation phase of the gland. Stem Cells Dev 2012; 21: 801-813.
69. Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, Le Tissier P, Jacques TS, Pevny LH, Dattani MT, Martinez-Barbera JP: Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol 2012; 124: 259-271.
70. Rizzoti K, Akiyama H, Lovell-Badge R: Mobilized adult pituitary stem cells contribute to endocrine regeneration in response to physiological demand. Cell Stem Cell 2013; 13: 419-432.
71. Andoniadou CL, Matsushima D, Mousavy Gharavy SN, Signore M, Mackintosh AI, Schaeffer M, Gaston-Massuet C, Mollard P, Jacques TS, Le Tissier P, Dattani MT, Pevny LH, Martinez-Barbera JP: Sox2+ stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell 2013; 13: 433-445.
72. Tatsi C, Sertedaki A, Voutetakis A, Valavani E, Magiakou MA, Kanaka-Gantenbein C, Chrousos GP, Dacou-Voutetakis C: Pituitary stalk interruption syndrome and isolated pituitary hypoplasia may be caused by mutations in holoprosencephaly-related genes. J Clin Endocrinol Metab 2013; 98:E779-E784.
73. Suga H, Kadoshima T, Minaguchi M, Ohgushi M, Soen M, Nakano T, Takata N, Wataya T, Muguruma K, Miyoshi H, Yonemura S, Oiso Y, Sasai Y: Self-formation of functional adenohypophysis in three-dimensional culture. Nature 2011; 480: 57-62.
74. Dincer Z, Piao J, Niu L, Ganat Y, Kriks S, Zimmer B, Shi SH, Tabar V, Studer L: Specification of functional cranial placode derivatives from human pluripotent stem cells. Cell Rep 2013; 5: 1387-1402.
75. Horsley V, Aliprantis AO, Polak L, Glimcher LH, Fuchs E: NFATc1 balances quiescence and proliferation of skin stem cells. Cell 2008; 132: 299-310.
76. Fuchs E, Horsley V: Ferreting out stem cells from their niches. Nat Cell Biol 2011; 13: 513-518.
77. Jirawatnotai S, Aziyu A, Osmundson EC, Moons DS, Zou X, Kineman RD, Kiyokawa H: Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J Biol Chem 2004; 279: 51100-51106.
78. Rane SG, Cosenza SC, Mettus RV, Reddy EP: Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol Cell Biol 2002; 22: 644-656.
79. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999; 22: 44-52.
80. Martin J, Hunt SL, Dubus P, Sotillo R, Nehme-Pelluard F, Magnuson MA, Parlow AF, Malumbres M, Ortega S, Barbacid M: Genetic rescue of Cdk4 null mice restores pancreatic betacell proliferation but not homeostatic cell number. Oncogene 2003; 22: 5261-5269.
81. Fu Q, Gremeaux L, Luque RM, Liekens D, Chen J, Buch T, Waisman A, Kineman R, Vankelecom H: The adult pituitary shows stem/ progenitor cell activation in response to injury and is capable of regeneration. Endocrinology 2012; 153: 3224-3235.
82. Fu Q, Vankelecom H: Regenerative capacity of the adult pituitary: multiple mechanisms of lactotrope restoration after transgenic ablation. Stem Cells Dev 2012; 21: 3245-3257.
83. Langlais D, Couture C, Kmita M, Drouin J: Adult pituitary cell maintenance: lineage-specific contribution of self-duplication. Mol Endocrinol 2013; 27: 1103-1112.
84. Schneeberger M, Altirriba J, Garcia A, Esteban Y, Castano C, Garcia-Lavandeira M, Alvarez CV, Gomis R, Claret M: Deletion of miRNA processing enzyme Dicer in POMC-expressing cells leads to pituitary dysfunction, neurodegeneration and development of obesity. Mol Metab 2012; 2: 74-85.
85. Nolan LA, Kavanagh E, Lightman SL, Levy A: Anterior pituitary cell population control: basal cell turnover and the effects of adrenalectomy and dexamethasone treatment. J Neuroendocrinol 1998; 10: 207-215.
86. Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S, Seandel M, Geijsen N, Hochedlinger K: Sox2+ adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 2011; 9: 317-329.
87. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, Hosokawa S, Elbahrawy A, Soeda T, Koizumi M, Masui T, Kawaguchi M, Takaori K, Doi R, Nishi E, Kakinoki R, Deng JM, Behringer RR, Nakamura T, Uemoto S: Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 2011; 43: 34-41.
88. Kulig E, Jin L, Qian X, Horvath E, Kovacs K, Stefaneanu L, Scheithauer BW, Lloyd RV: Apoptosis in nontumorous and neoplastic human pituitaries: expression of the Bcl-2 family of proteins. Am J Pathol 1999; 154: 767-774.
89. Vidal S, Horvath E, Kovacs K, Scheithauer BW, Lloyd RV, Kontogeorgos G: Ultrastructural features of apoptosis in human pituitary adenomas. Ultrastruct Pathol 2001; 25: 85-92.
90. Urbano AG, Suarez-Penaranda JM, Dieguez C, Alvarez CV: GDNF and RET-gene expression in anterior pituitary-cell types. Endocrinology 2000; 141: 1893-1896.
91. Japon MA, Urbano AG, Saez C, Segura DI, Cerro AL, Dieguez C, Alvarez CV: Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors. J Clin Endocrinol Metab 2002; 87: 1879-1884.
92. Canibano C, Rodriguez NL, Saez C, Tovar S, Garcia-Lavandeira M, Borrello MG, Vidal A, Costantini F, Japon M, Dieguez C, Alvarez CV: The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth. EMBO J 2007; 26: 2015-2028.
93. Delcros JG, Mehlen P: Dependence receptors: life or death choices. Bull Cancer 2013; 100: 1261-1274.
94. Diaz-Rodriguez E, Garcia-Rendueles AR, Ibanez-Costa A, Gutierrez-Pascual E, Garcia-Lavandeira M, Leal A, Japon MA, Soto A, Venegas E, Tinahones FJ, Garcia-Arnes JA, Benito P, Angeles Galvez M, Jimenez-Reina L, Bernabeu I, Dieguez C, Luque RM, Castano JP, Alvarez CV: Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/ p53 pathway that is blocked by excess GDNF. Endocrinology 2014; 155: 4329-4340.
95. Diaz-Rodriguez E, Garcia-Lavandeira M, Perez-Romero S, Senra A, Canibano C, Palmero I, Borrello MG, Dieguez C, Alvarez CV: Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/ p53-induced apoptosis in the pituitary somatotroph cells. Oncogene 2012; 31: 2824-2835.
96. Garcia-Lavandeira M, Diaz-Rodriguez E, Garcia-Rendueles ME, Rodrigues JS, Perez-Romero S, Bravo SB, Alvarez CV: Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary. Front Horm Res 2010; 38: 127-138.
97. Guillou A, Romano N, Bonnefont X, Le Tissier P, Mollard P, Martin AO: Modulation of the tyrosine kinase receptor Ret/glial cell-derived neurotrophic factor (GDNF) signaling: A new player in reproduction induced anterior pituitary plasticity? Endocrinology 2011; 152: 515-525.
98. Jaubert A, Drutel G, Leste-Lasserre T, Ichas F, Bresson-Bepoldin L: Tyrosine hydroxylase and dopamine transporter expression in lactotrophs from postlactating rats: involvement in dopamine-induced apoptosis. Endocrinology 2007; 148: 2698-2707.
99. Gadelha MR, Trivellin G, Hernandez Ramirez LC, Korbonits M: Genetics of pituitary adenomas. Front Horm Res 2013; 41: 111-140.
100. Maheshwari HG, Prezant TR, Herman-Bonert V, Shahinian H, Kovacs K, Melmed S: Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma. J Clin Endocrinol Metab 2000; 85: 3409-3416.
101. Xu Q, Yuan X, Tunici P, Liu G, Fan X, Xu M, Hu J, Hwang JY, Farkas DL, Black KL, Yu JS: Isolation of tumour stem-like cells from benign tumours. Br J Cancer 2009; 101: 303-311.
102. Karbanova J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerova H, Jaszai J, Ehrmann J, Kolar Z, Liebers C, Arl S, Subrtova D, Freund D, Mokry J, Huttner WB, Corbeil D: The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 2008; 56: 977-993.
103. Florio T: Recent evidence of putative human pituitary adenoma tumor stem cells (abstract S-3.3: 37). 14th Eur Neuroendocr Assoc Congr, Liège, 2010.
104. Mathioudakis N, Sundaresh R, Larsen A, Ruff W, Schiller J, Guerrero-Cazares H, Burger P, Salvatori R, Quinones-Hinojosa A: Expression of the pituitary stem/progenitor marker GFRalpha2 in human pituitary adenomas and normal pituitary. Pituitary 2015; 18: 31-41.
105. Kontogeorgos G, Sambaziotis D, Piaditis G, Karameris A: Apoptosis in human pituitary adenomas: A morphologic and in situ end-labeling study. Mod Pathol 1997; 10: 921-926.
106. Green VL, White MC, Hipkin LJ, Jeffreys RV, Foy PM, Atkin SL: Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas. Eur J Endocrinol 1997; 136: 382-387.
107. Kontogeorgos G, Horvath E, Kovacs K, Coire C, Lloyd RV, Scheithauer BW, Smyth HS: Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists. Acta Neuropathol 2006; 111: 46-52.
108. Saitoh Y, Arita N, Ohnishi T, Ekramullah S, Takemura K, Hayakawa T: Absence of apoptosis in somatotropinomas treated with octreotide. Acta Neurochir (Vienna) 1997; 139: 851-856.
109. Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S: Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 2002; 161: 1997-2001.
110. Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrubl F, Hahnen E, Kreutzer J, Fahlbusch R: Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 2005; 109: 589-597.
111. Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, et al: Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 2014; 46: 161-165.
112. Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, Kyeyune R, Vernay B, Jacques TS, Taketo MM, Le Tissier P, Dattani MT, Martinez-Barbera JP: Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci USA 2011; 108: 11482-11487.
113. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS: Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006; 124: 407-421.
114. Lucas D, Battista M, Shi PA, Isola L, Frenette PS: Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 2008; 3: 364-366.
115. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS: Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008; 452: 442-447.
116. Mazumdar J, O'Brien WT, Johnson RS, La-Manna JC, Chavez JC, Klein PS, Simon MC: O 2 regulates stem cells through Wnt/betacatenin signalling. Nat Cell Biol 2010; 12: 1007-1013.